|
|
|
|
ASH 49th Annual Meeting Itinerary: Abstracts pertinent to cord blood transplantation Sunday, December 9, 2007 Session Information: Simultaneous Session: Experimental Transplantation: Basic Biology and Immune Function (4:30 p.m.-6:00 p.m.) Title: [61] Umbilical Cord Blood T Cells Express the Natural Cytotoxicity Receptors, NKp30, NKp44 and NKp46 after IL-15 Stimulation, but Only NKp30 Is Functional. Session Type: Oral Session Session Information: Poster Session: Clinical Care: Transplantation Regimen Toxicities and Engraftment I (6:00 p.m.- 8:00 p.m.) Presentation Time: 6:00 pm Title: [2008] Flow Cytometric Analysis of Donor-Recipient Chimerism Using Anti-HLA Antibody after HLA-Mismatched Cord Blood Transplantation. Session Type: Poster Session, Board #198-II Session Information: Poster Session: Clinical Results: Alternative Donor Transplantation−Umbilical Cord Title: [2011] Comparative Single-Institute Analysis of Cord Blood Transplantation from Unrelated Donors with Unrelated Bone Marrow or Related Peripheral Blood Stem-Cell Transplants in Elderly Patients with Hematologic Diseases after Reduced Intensity-Conditioning Regimen. Session Type: Poster Session, Board #201-II Title: [2012] The Comparative Analysis of Bone Marrow Transplantation and Cord Blood Transplantation from Unrelated Donors in Patients with Myelodysplastic Syndrome in Japan. Session Type: Poster Session, Board #202-II Title: [2013] Unrelated Cord Blood Transplantation Using Myeloablative Regimen for Acute Leukemia Patients Aged between 50 and 55 Years: Single Institutional Retrospective Comparison with Patients Less Than 50 Years of Age. Session Type: Poster Session, Board #203-II Title: [2014] Randomized Study of Double Cord Blood Transplantation (CBT) with Versus without Ex-Vivo Expansion (EXP). Session Type: Poster Session, Board #204-II Title: [2015] CD34+ Viability Is a Critical Determinant of the Engraftment Potential of Umbilical Cord Blood (UCB) in Double Unit Transplantation. Session Type: Poster Session, Board #205-II Title: [2016] Double Umbilical Cord Blood Transplantation with Reduced Intensity Conditioning and Sirolimus-Based GVHD Prophylaxis. Session Type: Poster Session, Board #206-II Title: [2017] An International Multi-Institutional Study of Double Cord Blood Transplantation in a Racially Diverse Population. Session Type: Poster Session, Board #207-II Title: [2018] Double Cord Blood Transplantation in Bone Marrow Failure Syndromes. Session Type: Poster Session, Board #208-II Title: [2019] Outcomes in the Recent Seattle Cord Blood Experience: Low TRM and Relapse; High Mild Acute GVHD and CMV Reactivation. Session Type: Poster Session, Board #209-II Title: [2020] Unrelated Cord Blood Cell Transplantation for Acquired Severe Aplastic Anemia: The Report from the Japan Cord Blood Bank Network. Session Type: Poster Session, Board #210-II Title: [2021] Unrelated Cord Blood Transplantation for Children with Juvenile Myelomonocytic Leukemia. Session Type: Poster Session, Board #211-II Title: [2022] Risk Factors Analyses for Outcomes after Unrelated Cord Blood Transplantation for Children with Myelodysplastic Syndromes. An Analysis on Behalf of EWOG-MDS and Eurocord Groups. Session Type: Poster Session, Board #212-II Title: [2023] Cord Blood Transplantation from Unrelated Donors for Children with Acute Lymphoblastic Leukemia in Japan: The Impact of Methotrexate on the Clinical Outcome. Session Type: Poster Session, Board #213-II Title: [2025] Cord Blood Transplantation from Unrelated Donors for Adults with Advanced Lymphoid Malignancies - A Eurocord-Netcord Group/EBMT-LWP Study. Session Type: Poster Session, Board #215-II Title: [2026] Unrelated Cord Blood Transplanation for Malignant Lymphoma: A Retrospective Study fromn the Japan Cord Blood Bank Network (JCBNW). Session Type: Poster Session, Board #216-II Title: [2027] Unrelated Cord Blood Transplantation after Reduced Intensity Conditioning (RIC) in Adults with Hematological Malignancy. An EBMT−Eurocord−Netcord, Société Française de Greffe de Moelle et de Thérapie Cellulaire and University of Minnesota Collaborative Study. Session Type: Poster Session, Board #217-II Title: [2028] Encouraging Results of Reduced Intensity Conditioning (RIC) Umbilical Cord Blood (UCB) Transplantation for the Treatment of Advanced Lymphoid Malignancies. Session Type: Poster Session, Board #218-II Title: [2029] Cord Blood Transplantation after Non Myeloablative Conditioning (Minneapolis Protocol): Impact on Transplant Outcomes in 112 Adults with Hematologic Malignancy. A French Multicentric Study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and Eurocord. Session Type: Poster Session, Board #219-II Title: [2030] Umbilical Cord Blood Transplantation after Reduced−Intensity Conditioning for Adults: The Report from Japan Cord Blood Bank Network. Session Type: Poster Session, Board #220-II Title: [2032] HLA Locus-Specific Outcomes in Double Umbilical Cord Blood Reduced Intensity Transplantation (DCBT) in Adults. Session Type: Poster Session, Board #222-II Title: [2033] “Age” of the Cord Blood (CB) Unit: Impact of Long-Term Cryopreservation and Storage on Transplant Outcome. Session Type: Poster Session, Board #223-II Session Information: Poster Session: Hematopoietic Stem and Progenitor Biology II (6:00 p.m.−8:00 Title: [2238] Modulation of Responsiveness of Human CD34+ Cells to CXL12/SDF-1 through Desensitization of CXCR4 by CCR5 Chemokines: Possible Implications for Mobilization during Inflammation. Session Type: Poster Session, Board #428-II Title: [2243] Cobblestone Area-Forming Cell (CAFC) Content of Cord Blood Does Not Predict Engraftment in Double Cord Blood Transplantation. Session Type: Poster Session, Board #433-II Session Information: Poster Session: Lymphocytes, Natural Killer, and Dendritic Cells II (6:00 p.m.-8:00 p.m.) Title: [2297] Autologous Human Cord Blood CD4+CD25+ T Cells Stimulate CD8+ T Cell Killing Activity, and Their Expression of NKG2D and Granzyme B. Session Type: Poster Session, Board #487-II Session Information: Poster Session: Tumor Immunotherapy: T Cell and NK Cell Therapy (6:00 p.m.-8:00 p.m.) Title: [2741] Ex Vivo Expansion of Cord Blood NK Cell Have In Vivo Efficacy Against Leukemia. Session Type: Poster Session, Board #931-II Title: [2751] Anti−CD3 Activated T Cells from Cord Blood Can Be Expanded Ex Vivo and Armed with Bispecific Antibodies To Lyse Her2/Neu + and CD20+ Targets: A Strategy for Providing Anti-Tumor/Lymphoma Effects after Cord Blood Transplant. Session Type: Poster Session, Board #941-II
|
|
|
|
|
|
Page Updated
22 Nov 2007 |
Disclaimer: The Cord Blood Forum endorses collegial discussion among cord blood transplantation professionals, patients and donors. However, the Cord Blood Forum does not necessarily endorse, nor take any responsibility for the specific views and opinions expressed in the forum. The forum is not intended as a substitute for legal and/or medical advice and the content should not be relied upon for medical and/or legal purposes. Readers should make their own determinations as to: (i) what constitutes appropriate medical, technical, and administrative practices, and (ii) how best to comply with laws and regulations relevant to their questions. For the latter, they should consider consulting with an attorney familiar with related state and federal laws.
© 2008 Cord Blood Forum, Inc. 1601 N. Sepulveda Blvd. #729, Manhattan Beach, CA 90266 |
![]() |
![]() |